KORU Medical Systems, Inc.
$4.26
▲
1.17%
2026-04-21 07:46:00
www.korumedical.com
NCM: KRMD
Explore KORU Medical Systems, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$200.78 M
Current Price
$4.26
52W High / Low
$6.61 / $2.08
Stock P/E
—
Book Value
$0.37
Dividend Yield
—
ROCE
-14.86%
ROE
-15.58%
Face Value
—
EPS
$-0.06
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
73
Beta
0.54
Debt / Equity
20.51
Current Ratio
2.44
Quick Ratio
1.99
Forward P/E
49.53
Price / Sales
4.76
Enterprise Value
$189.84 M
EV / EBITDA
-83.27
EV / Revenue
4.62
Rating
Strong Buy
Target Price
$6.8
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
- Valuation is rich on a P/E basis.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Baxter International Inc. | $18.8 | — | $9.79 B | 0.21% | 1.04% | -13.71% | $32.68 / $15.73 | $11.92 |
| 2. | Retractable Technologies, Inc. | $0.65 | — | $19.46 M | 1.18% | -10.73% | -15.56% | $1.14 / $0.62 | $2.48 |
| 3. | Envista Holdings Corporation | $27.85 | 97.1 | $4.56 B | — | 4.89% | 1.56% | $30.42 / $14.72 | $18.96 |
| 4. | Utah Medical Products, Inc. | $70.22 | 20.02 | $225.9 M | 1.77% | 9.51% | 9.54% | $71.81 / $51.26 | $37.43 |
| 5. | Stereotaxis, Inc. | $1.98 | — | $192.55 M | — | -73.98% | -1.44% | $3.59 / $1.74 | $0.14 |
| 6. | Azenta, Inc. | $26.4 | — | $1.22 B | — | -1.19% | 1.53% | $41.73 / $19.87 | $37.26 |
| 7. | Anbio Biotechnology | $26.98 | 380.56 | $3.88 B | — | 11.61% | 27.05% | $55.65 / $6.05 | $0.63 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 10.9 M | 10.4 M | 10.19 M | 9.64 M | 8.84 M | — |
| Operating Profit | -0.55 M | -0.87 M | -0.31 M | -1.25 M | -1.59 M | — |
| Net Profit | -0.49 M | -0.78 M | -0.21 M | -1.17 M | -1.56 M | — |
| EPS in Rs | -0.01 | -0.02 | -0 | -0.03 | -0.03 | -0.03 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 41.13 M | 33.65 M | 28.52 M | 27.9 M |
| Operating Profit | -2.97 M | -6.45 M | -10.27 M | -10.78 M |
| Net Profit | -2.64 M | -6.07 M | -13.74 M | -8.66 M |
| EPS in Rs | -0.06 | -0.13 | -0.3 | -0.19 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 28.2 M | 27.22 M | 28.46 M | 42.33 M |
| Total Liabilities | 11.15 M | 10.4 M | 8.11 M | 11.01 M |
| Equity | 17.05 M | 16.81 M | 20.35 M | 31.33 M |
| Current Assets | 19.99 M | 19.13 M | 20.26 M | 29.8 M |
| Current Liabilities | 8.19 M | 7.2 M | 4.45 M | 6.96 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 0.46 M | -0.32 M | -4.89 M | -5.4 M |
| Investing CF | -0.95 M | -1.33 M | -0.81 M | -2.8 M |
| Financing CF | -0.22 M | -0.25 M | -0.22 M | 0.28 M |
| Free CF | -0.49 M | -1.66 M | -5.71 M | -8.21 M |
| Capex | -0.96 M | -1.34 M | -0.81 M | -2.8 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 17.98% | 2.23% | — | — |
| Earnings Growth % | 55.85% | -58.65% | — | — |
| Profit Margin % | -18.03% | -48.18% | -31.05% | — |
| Operating Margin % | -19.16% | -36.01% | -38.65% | — |
| Gross Margin % | 63.4% | 58.59% | 55.09% | — |
| EBITDA Margin % | -16.52% | -32.96% | -36.54% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.